Beijing Aleznova Pharmaceutical Research Institute Co., Ltd. ( China (Mainland))

Beijing Aleznova Pharmaceutical Research Institute Co. Ltd. is a high-tech company recognized by Scientific Commission of Beijing Municipality. It is also member of the pilot project launched by Beijing Patent's Affaires Bureau. It is founded in 1999 by scholars returned from the Occident and venture capitals.

The company is mainly engaged in the business of generic bio-chemical drugs development as well as the synthetic technological process studies. It obtains annually several dozens of new drugs clinical permits authorized by SFDA. Several patents have been authorized or open to public concerning NCE as well as synthetic technological process. Its products include Cyclobenzaprine hydrochloride with cas registry number of 6202-23-9, Isoxepac with cas registry number of 55453-87-7, Lornoxicam with cas registry number of 70374-39-9, Protected Imipenem with cas registry number of 98367-45-4, Biapenem with cas registry number of 120410-24-4,etc.

Beijing Aleznova also owns full set of facility from R&D, Pilot-scale to commercial production and quality testing, and has experienced technician and skilled workers to run various regular reactions as well as some reactions under special conditions:
(1). Facility in Laboratories for Chemical Synthesis: equipped with various kinds of suitable and efficient facility.
(2). Facility in Laboratories for Quality testing: GC, HPLC, IR, UV, KF Moisture Tester, Vacuum Drying Box, PH Meter, Optical Meter etc..
(3). Facility in workshop: Various size of reactor from 100L to 2000L, Various size Centrifuge, Vacuum Pump, High Vacuum Pump, Disintegrator, Batch Blender, Refrigerant Set, Hot Blast Circulation dryer, Evaporative- cooling crystallizer etc..